Puerol A is primarily used in pharmaceutical research due to its bioactive properties. It exhibits antioxidant and anti-inflammatory effects, making it a candidate for development in treatments targeting oxidative stress-related conditions such as neurodegenerative diseases and cardiovascular disorders. Studies suggest it may modulate cellular signaling pathways involved in inflammation and cell survival. Additionally, Puerol A has shown potential in skin care applications, where it helps protect against UV-induced damage and supports anti-aging formulations. Its natural origin and low toxicity profile enhance its suitability for use in nutraceuticals and cosmeceuticals.